NCT04415775

Brief Summary

The present proposal will evaluate the neural underpinnings of (a) the decline of mobility function in Parkinson's disease (PD), and (b) the effects of an innovative computer-guided dual-task (DT) mobility training platform (complementary approach: exercise intervention). Improved mobility functioning in PD, specifically balance, gait and cognition, directly translates to improved community ambulation as well as increased physical activity and social participation. These benefits are known to have a significant preventive and disease-modifying impact that surpasses any currently available pharmacological interventions. Outcomes of this research will provide new insights into brain plasticity mechanisms and will accelerate further optimization and commercialization of multi-modal mobility-cognitive training applications along with accompanying smart electronic monitoring tools. With wider usage of this training platform, rehabilitation specialists will be able to effectively scale services, while still monitoring quality and ensuring accountability. Thus, the study is highly transformative.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
67

participants targeted

Target at P75+ for not_applicable parkinson-disease

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 4, 2020

Completed
12 months until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

May 11, 2021

Status Verified

May 1, 2021

Enrollment Period

2.2 years

First QC Date

May 28, 2020

Last Update Submit

May 6, 2021

Conditions

Keywords

Dual task walkingTreadmill walkingPET scansParkinson Disease

Outcome Measures

Primary Outcomes (2)

  • NDWP scores

    NDWP scores on PET scans of participants will be analysed to identify gait impairment related imagining signatures during single and dual-task walking, and after intervention. They will also be compared to age-matched healthy controls using student t-test.

    10 weeks

  • Step Length Coefficient of Variability

    10 weeks

Study Arms (3)

Dual-task walking Intervention

EXPERIMENTAL
Other: Game based treadmill Program

Conventional Gait Rehabilitation

ACTIVE COMPARATOR
Other: Conventional Gait Rehabilitation

Healthy Controls

NO INTERVENTION

Interventions

Participants will be expected to play several cognitive computer games while standing on a sponge pad (10-min warm-up and while walking on the treadmill at your self-selected comfortable speed. (Dual-task treadmill training). This would be done in intervals of 2-4 min with rest periods for a total time of 35 minutes Treadmill speed and the difficulty level of the cognitive games will progress depending on participant performance and comfort level.

Dual-task walking Intervention

Participants will undergo a mixture of current gait training programs available for people with Parkinson's Disease. The protocol will be a Warm-up exercise consisting of rhythmical large movements (10 minutes), as well as video game practice while standing (i.e., single-task; 10 minutes). Treadmill walking in intervals of 2-4 minutes with rest periods. Walking over the ground while negotiating through obstacles. (10 minutes) The speed of the treadmill will be progressed gradually and as tolerated.

Conventional Gait Rehabilitation

Eligibility Criteria

Age55 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with idiopathic PD, defined by the UK Brain Bank criterion in disease stage 2 - 3 (classified by Hoehn and Yahr scale),
  • Montreal cognitive assessment (MoCA) scores to be 25 or higher
  • Age 55-70 years
  • Stable medications for Parkinson over the past 3 months
  • Able to walk at least 50m without any assistive device
  • Episode of FOG in the past 6 months

You may not qualify if:

  • The presence of neurological conditions other than PD affecting cognitive abilities.
  • Any orthopedic impairment affecting gait and balance.
  • Any cardiovascular impairment limiting the ability to walk for 10-15 minutes on a treadmill;
  • Abnormal MRI
  • General contraindications.
  • Age 55-70 years,
  • Independent community living,
  • Not receiving any home care or Physiotherapy,
  • Walking outdoors for exercise for at least 3 times per week,
  • No neurological conditions affecting mobility or affecting cognitive abilities,
  • Any orthopedic impairment affecting gait and balance.
  • Any cardiovascular impairment limiting the ability to walk for 10-15 minutes on a treadmill.
  • Abnormal MRI and
  • General contraindications for PET and MRI including severe dyskinesia, diabetes, cardiac pacemakers.
  • Any orthopedic impairment affecting gait and balance.
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

College of Rehabilitation Sciences, University of Manitoba

Winnipeg, Manitoba, R3E 0T6, Canada

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: One experimental group and other control group receiving control intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 28, 2020

First Posted

June 4, 2020

Study Start

June 1, 2021

Primary Completion

August 1, 2023

Study Completion

November 1, 2023

Last Updated

May 11, 2021

Record last verified: 2021-05

Locations